CIK 0001650648
- Non-accelerated filer
- Smaller reporting company
4D Molecular Therapeutics, Inc.
Sign in to watch- Ticker
- FDMT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 473506994
- Phone
- +1 510-505-2680
- Business address
- 5858 HORTON STREET #455, EMERYVILLE, CA, 94608
- Former names
- 4D Molecular Therapeutics Inc., 4D Molecular Therapeutics Inc
- 4 Gift Chief Executive Officer gave 600,000 shares (gift)
- 4 Planned sale Chief Legal and HR Officer sold 3,750 shares at $20.00 ($75,000)
- 4 Planned sale Director sold 5,000 shares at $20.05 ($100,270)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Legal and HR Officer sold 2,248 shares at $19.30 ($43,386)
- 4 Open-market sale Chief Executive Officer sold 34,446 shares at an average $20.61 ($709,873)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Executive Officer sold 19,524 shares at an average $20.10 ($392,474)
- 4 Option exercise Chief Financial Officer acquired 3,000 shares (option exercise)
- 4 Open-market sale Chief Executive Officer sold 86,877 shares at an average $23.23 ($2,018,344)
- 4 Open-market sale Chief Legal and HR Officer sold 6,000 shares at an average $22.79 ($136,725)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 6 of 9 · 170 filings